Your browser doesn't support javascript.
loading
T-cell trans-synaptic vesicles are distinct and carry greater effector content than constitutive extracellular vesicles.
Céspedes, Pablo F; Jainarayanan, Ashwin; Fernández-Messina, Lola; Valvo, Salvatore; Saliba, David G; Kurz, Elke; Kvalvaag, Audun; Chen, Lina; Ganskow, Charity; Colin-York, Huw; Fritzsche, Marco; Peng, Yanchun; Dong, Tao; Johnson, Errin; Siller-Farfán, Jesús A; Dushek, Omer; Sezgin, Erdinc; Peacock, Ben; Law, Alice; Aubert, Dimitri; Engledow, Simon; Attar, Moustafa; Hester, Svenja; Fischer, Roman; Sánchez-Madrid, Francisco; Dustin, Michael L.
Afiliação
  • Céspedes PF; Kennedy Institute of Rheumatology, Nuffield Department of Orthopedics, Rheumatology and Musculoskeletal Sciences, The University of Oxford, Oxford, UK. pablo.cespedes@kennedy.ox.ac.uk.
  • Jainarayanan A; Kennedy Institute of Rheumatology, Nuffield Department of Orthopedics, Rheumatology and Musculoskeletal Sciences, The University of Oxford, Oxford, UK.
  • Fernández-Messina L; Immunology Service, Hospital de la Princesa, Instituto Investigación Sanitaria Princesa, Universidad Autónoma de Madrid, Madrid, Spain.
  • Valvo S; Intercellular communication in the inflammatory response. Vascular Physiology Area, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
  • Saliba DG; Kennedy Institute of Rheumatology, Nuffield Department of Orthopedics, Rheumatology and Musculoskeletal Sciences, The University of Oxford, Oxford, UK.
  • Kurz E; Kennedy Institute of Rheumatology, Nuffield Department of Orthopedics, Rheumatology and Musculoskeletal Sciences, The University of Oxford, Oxford, UK.
  • Kvalvaag A; Kennedy Institute of Rheumatology, Nuffield Department of Orthopedics, Rheumatology and Musculoskeletal Sciences, The University of Oxford, Oxford, UK.
  • Chen L; Kennedy Institute of Rheumatology, Nuffield Department of Orthopedics, Rheumatology and Musculoskeletal Sciences, The University of Oxford, Oxford, UK.
  • Ganskow C; Kennedy Institute of Rheumatology, Nuffield Department of Orthopedics, Rheumatology and Musculoskeletal Sciences, The University of Oxford, Oxford, UK.
  • Colin-York H; Kennedy Institute of Rheumatology, Nuffield Department of Orthopedics, Rheumatology and Musculoskeletal Sciences, The University of Oxford, Oxford, UK.
  • Fritzsche M; Kennedy Institute of Rheumatology, Nuffield Department of Orthopedics, Rheumatology and Musculoskeletal Sciences, The University of Oxford, Oxford, UK.
  • Peng Y; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, The University of Oxford, Oxford, UK.
  • Dong T; Kennedy Institute of Rheumatology, Nuffield Department of Orthopedics, Rheumatology and Musculoskeletal Sciences, The University of Oxford, Oxford, UK.
  • Johnson E; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, The University of Oxford, Oxford, UK.
  • Siller-Farfán JA; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, The University of Oxford, Oxford, UK.
  • Dushek O; Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), University of Oxford, Oxford, UK.
  • Sezgin E; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, The University of Oxford, Oxford, UK.
  • Peacock B; Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), University of Oxford, Oxford, UK.
  • Law A; Sir William Dunn School of Pathology, The University of Oxford, Oxford, UK.
  • Aubert D; Sir William Dunn School of Pathology, The University of Oxford, Oxford, UK.
  • Engledow S; Sir William Dunn School of Pathology, The University of Oxford, Oxford, UK.
  • Attar M; Science for Life Laboratory, Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
  • Hester S; NanoFCM, MediCity, Nottingham, UK.
  • Fischer R; NanoFCM, MediCity, Nottingham, UK.
  • Sánchez-Madrid F; NanoFCM, MediCity, Nottingham, UK.
  • Dustin ML; Oxford Genomics Centre, Wellcome Centre for Human Genetics, The University of Oxford, Oxford, UK.
Nat Commun ; 13(1): 3460, 2022 06 16.
Article em En | MEDLINE | ID: mdl-35710644
ABSTRACT
The immunological synapse is a molecular hub that facilitates the delivery of three activation signals, namely antigen, costimulation/corepression and cytokines, from antigen-presenting cells (APC) to T cells. T cells release a fourth class of signaling entities, trans-synaptic vesicles (tSV), to mediate bidirectional communication. Here we present bead-supported lipid bilayers (BSLB) as versatile synthetic APCs to capture, characterize and advance the understanding of tSV biogenesis. Specifically, the integration of juxtacrine signals, such as CD40 and antigen, results in the adaptive tailoring and release of tSV, which differ in size, yields and immune receptor cargo compared with steadily released extracellular vesicles (EVs). Focusing on CD40L+ tSV as model effectors, we show that PD-L1 trans-presentation together with TSG101, ADAM10 and CD81 are key in determining CD40L vesicular release. Lastly, we find greater RNA-binding protein and microRNA content in tSV compared with EVs, supporting the specialized role of tSV as intercellular messengers.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ligante de CD40 / Vesículas Extracelulares Tipo de estudo: Prognostic_studies Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ligante de CD40 / Vesículas Extracelulares Tipo de estudo: Prognostic_studies Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido